281 results on '"Iggo, Richard"'
Search Results
2. Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research
3. Lentiviral Transduction of Mammary Epithelial Cells
4. Modeling Breast Cancer in Organoid and Intraductal Models
5. The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
6. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations
7. Selective inhibition of CDK9 in triple negative breast cancer
8. Annexin‐A5 and annexin‐A6 silencing prevents metastasis of breast cancer cells in zebrafish
9. Supplementary figures from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
10. Data from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
11. Supplementary Data from Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter
12. The p68 RNA helicase
13. Inhibition of the membrane repair protein annexin-A2 prevents tumour invasion and metastasis
14. ACSM1 and ACSM3 regulate prostate cancer fatty acid metabolism to promote tumour growth and constrain ferroptosis
15. Patient-derived xenograft (PDX) models in basic and translational breast cancer research
16. TBK1 is part of a galectin 8 dependent membrane damage recognition complex and drives autophagy upon Adenovirus endosomal escape
17. Inhibition of membrane repair protein annexin-A2 prevents tumor invasion and metastasis
18. Annexin-A5 and annexin-A6 silencing prevents metastasis of breast
19. TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
20. Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer
21. Lentiviral Transduction of Mammary Epithelial Cells
22. p53 mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients
23. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
24. Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer
25. Validation of a yeast functional assay for p53 mutations using clonal sequencing
26. A genome-scale CRISPR knock-out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling
27. Identification of molecular apocrine breast tumours by microarray analysis
28. Promoter-specific p53-dependent histone acetylation following DNA damage
29. Models incorporating chromatin modification data identify functionally important p53 binding sites
30. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
31. The Androgen Receptor is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
32. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast
33. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay
34. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay
35. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology
36. Determinants of interferon-stimulated gene induction by RNAi vectors
37. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants
38. A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening
39. Increased expression of mutant forms of p53 oncogene in primary lung cancer
40. Classification of breast tumours into molecular apocrine, luminal and basal groups based on an explicit biological model
41. Homozygous p53 Gene Mutation in a Radiation-induced Glioblastoma 10 Years after Treatment for an Intracranial Germ Cell Tumor: Case Report
42. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells
43. Classification of breast tumours into molecular apocrine, luminal and basal groups based on an explicit biological model
44. Cluster Analysis of p53 Binding Site Sequences Reveals Subsets with Different Functions
45. The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells
46. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
47. MICADo – Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method
48. Identification of Imatinib-Sensitizing Genes in Chronic Myeloid Leukemia with a Genome-Scale Crispr Knock-out Screen
49. Looking for mutations in PacBio cancer data: an alignment-free method
50. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCHand CREBBPmutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.